Matthew Moyle
2017
In 2017, Matthew Moyle earned a total compensation of $326.7K as Chief Scientific Officer at ANAPTYSBIO, a 63% decrease compared to previous year.
Compensation breakdown
| Salary | $182,975 |
|---|---|
| Other | $143,704 |
| Total | $326,679 |
Moyle received $183K in salary, accounting for 56% of the total pay in 2017.
Moyle also received $143.7K in other compensation.
Rankings
In 2017, Matthew Moyle's compensation ranked 13,121st out of 14,666 executives tracked by ExecPay. In other words, Moyle earned more than 10.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 13,121 out of 14,666 | 11th |
Division Manufacturing | 5,166 out of 5,772 | 11th |
Major group Chemicals And Allied Products | 1,874 out of 2,075 | 10th |
Industry group Drugs | 1,562 out of 1,731 | 10th |
Industry Pharmaceutical Preparations | 1,209 out of 1,333 | 9th |
Source: SEC filing on April 26, 2018.
Moyle's colleagues
We found three more compensation records of executives who worked with Matthew Moyle at ANAPTYSBIO in 2017.